AI assistant
Sending…
Co-Diagnostics, Inc. — Director's Dealing 2020
May 22, 2020
35011_dirs_2020-05-21_eab704e0-c907-405d-ac91-1f729139dc90.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2020-05-19
Reporting Person: SERBIN RICHARD S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-19 | Common Stock | M | 25000 | $0.71 | Acquired | 25000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-05-19 | Non-Qualified Stock Option (right to buy) | $0.71 | M | 25000 | Disposed | 2029-04-23 | Common Stock (0) | Direct |
Footnotes
F1: All shares underlying this option have vested.
More from Co-Diagnostics, Inc.
Capital/Financing Update
2026
May 28
Capital/Financing Update
2026
May 21
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
Feb 11
Regulatory Filings
2026
Jan 21
Delisting Announcement
2026
Jan 13
Share Issue/Capital Change
2025
Dec 30
Capital/Financing Update
2025
Dec 19
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 5